Atossa Therapeutics
ATOS
#9237
Rank
A$0.15 B
Marketcap
A$1.20
Share price
5.24%
Change (1 day)
-36.87%
Change (1 year)

Atossa Therapeutics (ATOS) - Net assets

Net assets on the balance sheet as of June 2025 : A$86.85 Million

According to Atossa Therapeutics's latest financial reports the company has A$86.85 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Atossa Therapeutics - Net assets on balance sheet (from 2010 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$0.11 B-13.98%
2023-12-31$A$0.13 B-22.93%
2022-12-31$A$0.17 B-9.02%
2021-12-31$A$0.19 B439.27%
2020-12-31$A$35.33 M88.03%
2019-12-31$A$18.79 M50.34%
2018-12-31$A$12.49 M40.63%
2017-12-31$A$8.88 M106.86%
2016-12-31$A$4.29 M-16.35%
2015-12-31$A$5.13 M-55.74%
2014-12-31$A$11.6 M-2.35%
2013-12-31$A$11.88 M138.65%
2012-12-31$A$4.98 M227.4%
2011-12-31$A$1.52 M-281.39%
2010-12-31$-A$0.84 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
A$119.35 B 137,307.05%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$13.11 B 15,001.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$11.10 B 12,684.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
A$65.33 M-24.78%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
A$1.26 B 1,352.97%๐Ÿ‡บ๐Ÿ‡ธ USA